BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He Y, Huang W, Zhang C, Chen L, Xu R, Li N, Wang F, Han L, Yang M, Zhang D. Energy metabolism disorders and potential therapeutic drugs in heart failure. Acta Pharm Sin B 2021;11:1098-116. [PMID: 34094822 DOI: 10.1016/j.apsb.2020.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Feng K, Yuan L, Liu Y, Zhang M, Guo K, Yin Z, Wang W, Zhou S, Sun H, Yan K, Yan X, Wang X, Duan Y, Hu Y, Han J. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.012] [Reference Citation Analysis]
2 Chen H, Jiang R, Huang W, Chen K, Zeng R, Wu H, Yang Q, Guo K, Li J, Wei R, Liao S, Tse HF, Sha W, Zhuo Z. Identification of energy metabolism-related biomarkers for risk prediction of heart failure patients using random forest algorithm. Front Cardiovasc Med 2022;9:993142. [PMID: 36304554 DOI: 10.3389/fcvm.2022.993142] [Reference Citation Analysis]
3 Sweed E, Sweed D, Galal N, Abd-elhafiz HI. Dapagliflozin Protection against Myocardial Ischemia by Modulating Sodium-glucose Transporter 2 Inhibitor, Silent Information Regulator 1, and Fatty Acid Synthase Expressions. Open Access Maced J Med Sci 2022;10:1544-1554. [DOI: 10.3889/oamjms.2022.10861] [Reference Citation Analysis]
4 Gao Y, Feng S, Wen Y, Tang T, Wang B, Liu B. Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming. eBioMedicine 2022;83:104215. [DOI: 10.1016/j.ebiom.2022.104215] [Reference Citation Analysis]
5 Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev 2022;81:101706. [PMID: 35932976 DOI: 10.1016/j.arr.2022.101706] [Reference Citation Analysis]
6 Yu H, Fu J, Guo HH, Pan LB, Xu H, Zhang ZW, Hu JC, Yang XY, Zhang HJ, Bu MM, Lin Y, Jiang JD, Wang Y. Metabolites Analysis of Anti-Myocardial Ischemia Active Components of Saussurea involucrata Based on Gut Microbiota-Drug Interaction. Int J Mol Sci 2022;23:7457. [PMID: 35806462 DOI: 10.3390/ijms23137457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Aiyasiding X, Liao HH, Feng H, Zhang N, Lin Z, Ding W, Yan H, Zhou ZY, Tang QZ. Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway. Front Pharmacol 2022;13:870699. [PMID: 35592411 DOI: 10.3389/fphar.2022.870699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang A, Zhao W, Yan K, Huang P, Zhang H, Zhang Z, Zhang D, Ma X. Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure. Front Pharmacol 2022;13:810587. [PMID: 35281941 DOI: 10.3389/fphar.2022.810587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yu Y, Chen W, Yu M, Liu J, Sun H, Yang P. Exercise-Generated β-Aminoisobutyric Acid (BAIBA) Reduces Cardiomyocyte Metabolic Stress and Apoptosis Caused by Mitochondrial Dysfunction Through the miR-208b/AMPK Pathway. Front Cardiovasc Med 2022;9:803510. [DOI: 10.3389/fcvm.2022.803510] [Reference Citation Analysis]
10 Qi Y, Tang Y, Yin L, Ding K, Zhao C, Yan W, Yao Y. miR-129-5p restores cardiac function in rats with chronic heart failure by targeting the E3 ubiquitin ligase Smurf1 and promoting PTEN expression. Bioengineered 2022;13:2371-86. [PMID: 35034538 DOI: 10.1080/21655979.2021.2024335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Salikova SP, Grinevich VB, Vlasov AA. The Modern Aspects of Nutrition during Chronic Heart Failure. jour 2022. [DOI: 10.31146/1682-8658-ecg-196-12-62-73] [Reference Citation Analysis]
12 Cao M, Zhao Q, Sun X, Qian H, Lyu S, Chen R, Xia H, Yuan W. Sirtuin 3: Emerging therapeutic target for cardiovascular diseases. Free Radic Biol Med 2022;180:63-74. [PMID: 35031448 DOI: 10.1016/j.freeradbiomed.2022.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
13 Shao-Mei W, Li-Fang Y, Li-Hong W. Traditional Chinese medicine enhances myocardial metabolism during heart failure. Biomed Pharmacother 2021;146:112538. [PMID: 34922111 DOI: 10.1016/j.biopha.2021.112538] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tan KS, Wang D, Lu Z, Zhang Y, Li S, Lin Y, Tan W. CNPase, a 2',3'-Cyclic-nucleotide 3'-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production. Int J Mol Sci 2021;22:10806. [PMID: 34639145 DOI: 10.3390/ijms221910806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]